Cytosorbents (CTSO) Operating Income (2011 - 2026)
Cytosorbents' (CTSO) quarterly Operating Income came in at -$3.0 million in Q1 2026, up 21.71% YoY from -$2.5 million in Q1 2025, and up 30.58% on a QoQ basis from -$4.4 million in Q4 2025.
Cytosorbents (CTSO) Operating Income (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Operating Income data on file, last reported at -$3.0 million in Q1 2026.
- Quarterly Operating Income rose 21.71% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.9 million (up 11.33% YoY) and the FY2025 annual result came in at -$14.7 million, up 10.35% from the prior year.
- Operating Income improved to -$3.0 million in Q1 2026, from -$4.4 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$2.9 million in Q3 2025 to a low of -$9.4 million in Q4 2023.
- A 5-year average of -$5.7 million and a median of -$4.8 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 173.16% — and 2024, when it jumped 63.91%.
- Tracing CTSO's Operating Income over 5 years: stood at -$6.4 million in 2022, then tumbled by 48.01% to -$9.4 million in 2023, then jumped by 63.91% to -$3.4 million in 2024, then fell by 29.16% to -$4.4 million in 2025, then jumped by 30.58% to -$3.0 million in 2026.
- The last three Operating Income figures came in at -$3.0 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.64 Mn |
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -4.39 Mn |
| Sep 30, 2025 | -2.86 Mn |
| Jun 30, 2025 | -3.62 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | -3.40 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | -4.66 Mn |
| Dec 31, 2023 | -9.41 Mn |
| Sep 30, 2023 | -7.35 Mn |
| Jun 30, 2023 | -6.56 Mn |
| Mar 31, 2023 | -7.89 Mn |
| Dec 31, 2022 | -6.36 Mn |
| Sep 30, 2022 | -9.02 Mn |
| Jun 30, 2022 | -8.36 Mn |
| Mar 31, 2022 | -7.79 Mn |
| Dec 31, 2021 | -9.56 Mn |
| Sep 30, 2021 | -5.41 Mn |